An Update of Anticoagulant Strategies in Non-critically Ill Patients Hospitalized with COVID-19

Abstract

After 3 years since the start of the COVID-19 pandemic, the World Health Organization declares end to COVID-19 global public health emergency in May 2023. Due to the hypercoagulable state of this disease, many studies have been conducted on the role of prophylactic or therapeutic anticoagulants in reducing mortality and occurrence of thromboembolic events. Despite numerous studies, optimal anticoagulant strategies in noncritically ill patients hospitalized with COVID-19 remains unknown.